Market Overview:
The global tissue microarrayer market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for tissue microarrays in pathological labs, research centers, and clinical centers. Additionally, the growing focus on precision medicine is also propelling the growth of this market. However, high cost of fully automated tissue microarrayers may restrain the growth of this market during the forecast period.
Product Definition:
A tissue microarrayer is a device used to create tissue microarrays, which are collections of small pieces of human tissue that have been arrayed on a microscope slide. Tissue microarrays are important for studying the distribution and behavior of cancer cells within tumors.
Fully Automated:
Fully automated systems are used for the collection of tissue samples and their subsequent analysis. The factors that propel the growth of this market include increasing prevalence of chronic diseases, rising geriatric population base, and growing demand for rapid diagnostic tests. Moreover, technological advancements in sample preparation techniques drive market growth during the forecast period.
Semi-Automated:
Semi-automatic tissue microarrayer is a device that helps in the collection of data from multiple tissue samples and also helps to process, analyze, and export the data. It is an important tool used for research purposes as it allows easy access to large amounts of biological information.
Advantages: It reduces labor intensity by half; it increases productivity by allowing more samples per unit time; it minimizes errors due to its robust design & user interface;.
Application Insights:
The research centers application segment accounted for the largest revenue share in 2017 and is projected to expand at a steady CAGR over the forecast period. The use of tissue microarrays in cancer research has increased significantly owing to their benefits, such as ease of use, rapidity with which results can be obtained and reduced cost when compared with other techniques used for genetic analysis.
Clinical center application segment is expected to witness significant growth during the forecast period due to increasing adoption of Tissue Microarrayer by clinical researchers worldwide. Adoption of this technology helps reduce costs associated with multiple trips between laboratory and hospital staff involved in tumor biopsy or surgical specimen collection & subsequent processing & diagnosis procedures. These factors are anticipated to boost demand over the coming years.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high investment in R&D, and increasing demand for advanced diagnostic technologies. Moreover, growing prevalence of cancer and other chronic diseases is expected to boost regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising awareness about availability of tissue microarrays as well as increasing healthcare expenditure by governments across various countries including China & India.
Key players operating in this industry include Affymetrix Inc.; Agilent Technologies; Bio-Rad Laboratories; Corning Clinical Diagnostics; EMD Millipore Corporation; Fujifilm Medical Systems Co., Ltd.; Hygiena LLC.; IBA Biosciences Corp.; Roche Molecular Systems AG & Co., Ltd.
Growth Factors:
- Increasing demand for tissue microarrays in research and drug discovery
- Rising prevalence of cancer and other diseases
- Technological advancements in tissue microarrayer instruments
- Growing number of collaborations between pharmaceutical companies and research institutes for tissue microarray development
- Increasing awareness about the benefits of using tissue microarrays
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Microarrayer Market Research Report
By Type
Fully Automated, Semi-Automated, Manual
By Application
Pathological Labs, Research Centers, Clinical Centers
By Companies
Arrayit Corporation, BioVendor, BioChain Institute, 3DHISTECH, Thermo Fisher Scientific, Diagnostic Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Microarrayer Market Report Segments:
The global Tissue Microarrayer market is segmented on the basis of:
Types
Fully Automated, Semi-Automated, Manual
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pathological Labs, Research Centers, Clinical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Arrayit Corporation
- BioVendor
- BioChain Institute
- 3DHISTECH
- Thermo Fisher Scientific
- Diagnostic Technology
Highlights of The Tissue Microarrayer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automated
- Semi-Automated
- Manual
- By Application:
- Pathological Labs
- Research Centers
- Clinical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Microarrayer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A tissue microarrayer is a type of medical imaging device that uses light to image the tissues of the body. Tissue microarrays are often used in research to study how different diseases affect different parts of the body.
Some of the key players operating in the tissue microarrayer market are Arrayit Corporation, BioVendor, BioChain Institute, 3DHISTECH, Thermo Fisher Scientific, Diagnostic Technology.
The tissue microarrayer market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tissue Microarrayer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tissue Microarrayer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tissue Microarrayer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tissue Microarrayer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tissue Microarrayer Market Size & Forecast, 2020-2028
4.5.1 Tissue Microarrayer Market Size and Y-o-Y Growth
4.5.2 Tissue Microarrayer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Fully Automated
5.2.2 Semi-Automated
5.2.3 Manual
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pathological Labs
6.2.2 Research Centers
6.2.3 Clinical Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tissue Microarrayer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tissue Microarrayer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Fully Automated
9.6.2 Semi-Automated
9.6.3 Manual
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pathological Labs
9.10.2 Research Centers
9.10.3 Clinical Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Fully Automated
10.6.2 Semi-Automated
10.6.3 Manual
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pathological Labs
10.10.2 Research Centers
10.10.3 Clinical Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Fully Automated
11.6.2 Semi-Automated
11.6.3 Manual
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pathological Labs
11.10.2 Research Centers
11.10.3 Clinical Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Fully Automated
12.6.2 Semi-Automated
12.6.3 Manual
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pathological Labs
12.10.2 Research Centers
12.10.3 Clinical Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Fully Automated
13.6.2 Semi-Automated
13.6.3 Manual
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pathological Labs
13.10.2 Research Centers
13.10.3 Clinical Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tissue Microarrayer Market: Competitive Dashboard
14.2 Global Tissue Microarrayer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Arrayit Corporation
14.3.2 BioVendor
14.3.3 BioChain Institute
14.3.4 3DHISTECH
14.3.5 Thermo Fisher Scientific
14.3.6 Diagnostic Technology
